IC47

· Valneva Austria GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IC47, covering 2012-10-19 to 2012-10-19. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Study Assessing The Safety, Immunogenicity and Dose Response of IC47 [Phase 1]